ACROSTUDY: Pegvisomant safe, effective for long-term use in acromegaly
August 24, 2021
While discussing a study that found the drug pegvisomant is safe and effective in treating aggressive, uncontrolled or active forms of the condition acromegaly that need long-term treatment, Maria Fleseriu, M.D., says: “Pegvisomant had a favorable safety profile in clinical practice, especially concerning pituitary tumor volumes and liver tests.”